Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Investors Reacted to The Latest Earnings Reports of These Companies

Page 1 of 2

Most investors are smiling today, as the US stock market continues its rally, with the Dow setting a new intraday high. Oil prices are also surging after the EIA reported a decline in inventories by 2.3 million barrels. With the earnings season picking up steam, let’s take a look at five companies that reported their second quarter results this morning and how investors reacted to the numbers.

At Insider Monkey, we track around 770 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

background, modern, room,

ImageFlow/Shutterstock.com

Abbott Laboratories (NYSE:ABT) is up this morning, having managed to surpass analysts’ estimates for both revenue and earnings. The company reported $5.33 billion in revenue, up by 3% year-over-year, and adjusted earnings of $0.55 per share, topping projections of $0.53 per share on the back of $5.26 billion in revenue. Abbott Laboratories (NYSE:ABT) said its medical device unit registered the strongest performance during the quarter, followed by its endovascular business. The company also noted that political turmoil in Venezuela have had a significant impact on revenues from emerging markets. Among the hedge funds followed by Insider Monkey, 42 of them were invested in Abbott Laboratories (NYSE:ABT) at the end of the first quarter, up from 39 a quarter before.

Follow Abbott Laboratories (NYSE:ABT)
Trade (NYSE:ABT) Now!

Stock Soaring On Earnings Beat

Amphenol Corporation (NYSE:APH) shareholders are all smiles this morning, as shares are trending higher following the release of the earnings report. For the second quarter, the company posted a net income of $206.5 million or $0.65 per share, beating estimates of $0.63 per share. Revenues came in at $1.55 billion, while analysts were looking for $1.52 billion. Amphenol Corporation (NYSE:APH) said it expects third quarter revenue to range between $1.54 billion to $1.58 billion, with analysts having estimated revenues of $1.58 billion. The company has a market cap of $18 billion and pays an annual dividend of $0.55 per share, providing investors with a 0.93% yield. Hedge fund sentiment towards Amphenol Corporation (NYSE:APH) was unchanged during the first three months of 2016, with 16 of the funds in our database having reported a long position as of the end of March.

Follow Amphenol Corp (NYSE:APH)
Trade (NYSE:APH) Now!

Head to the next page to read about three other earnings reports and how investors are trading the news.

Page 1 of 2
Loading Comments...